Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;23(3):253-60.
doi: 10.1007/s13337-012-0058-3. Epub 2012 Mar 20.

Recent Advances in Development of DNA Vaccines Against Hepatitis C virus

Sami Ullah  1 , Muhammad Ali A Shah, Nosheen Riaz
Affiliations
Review

Recent Advances in Development of DNA Vaccines Against Hepatitis C virus

Sami Ullah et al. Indian J Virol. 2012 Dec.

Abstract

Hepatitis C is one of the foremost challenging diseases all over the world. No vaccine has been developed, yet against Hepatitis C virus (HCV). This is partly due to the high mutation rate in the HCV genome, which generates new genotypes and sub genotypes. A mass of efforts have been devoted for the development of an efficient vaccine against HCV. DNA Vaccines, an emerging field of Vaccinology, grasp strong potential to be the most reliable and efficient mode of vaccination in the future. This technology is under investigation currently. Incredibly diverse approaches have been applied as an endeavor to develop a potent DNA vaccine against HCV. The HCV structural genes and the virus like particles have been attempted and so far the results are quite promising in the Lab animals. As there is no proper animal model for HCV infection except chimpanzees, it is very difficult to articulate whether these vaccines will also be pertinent in humans or not. This review will focus on different approaches being used for the development of DNA vaccines, the major tribulations in designing a DNA vaccine against HCV as well as the future prospects for the improvement of under trials DNA vaccines developed against HCV.

Keywords: DNA vaccines; HCV; Virus like particles.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Epidemiology of hepatitis C virus around the globe in 2010. Courtesy by Lavanchy [22]
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ali SMA, Lixin X, Ruofeng Y, Xiaokai S, Xiangrui L. Construction of DNA vaccines encoding Eimeria acervulina cSZ-2 with chicken IL-2 and IFN-γ and their induced immunity against poultry Coccidiosis. Res Vet Sci. 2011;90:72–77. doi: 10.1016/j.rvsc.2010.05.003. - DOI - PubMed
    1. Alvarez LL, Carrera SD. Commentary advances in DNA immunization against hepatitis C virus infection. Opportunities and challenges. Human Vaccines. 2009;5:568–70. - PubMed
    1. Arashkia A, Roohvand F, Memarnejadian A, Aghasadeghi MR, Rafati S. Construction of HCV-polytope vaccine candidates harboring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice. Virus Genes. 2009;40:44–52. doi: 10.1007/s11262-009-0417-3. - DOI - PubMed
    1. Arribillaga L, de Cerio AL, Sarobe P, Casares N, Gorraiz M, Vales A, Bruna-Romero O, Borras-Cuesta F, Paranhos-Baccala G, Prieto J, Ruiz J, Lasarte JJ. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Vaccine. 2002;21:202–210. doi: 10.1016/S0264-410X(02)00456-5. - DOI - PubMed
    1. Britton RA, Lin DC, Grossman AD. Characterization of a prokaryotic SMC protein involved in chromosome partitioning. Genes Dev. 1998;12:1254–1259. doi: 10.1101/gad.12.9.1254. - DOI - PMC - PubMed

LinkOut - more resources